Table 4 Impact of Significant Treatment Variables on Treatment Satisfaction
| Â | ITSQ Overall (n = 197) | ITSQ IR (n = 196) | ITSQ LF (n = 196) | ITSQ HC (n = 197) | ITSQ GC (n = 197) | ITSQ DD (n = 197) |
|---|---|---|---|---|---|---|
| Â | Coefficient (t-ratio) | |||||
Intercept | 108.93*** (13.06) | 110.62*** (11.53) | 62.46*** (7.52) | 84.27*** (43.10) | 124.26*** (12.73) | 108.68*** (12.34) |
Age | Â | Â | 0.32* (2.04) | Â | Â | Â |
Neuropathy (N = 0, Y = 1) | -11.91** (-2.79) | -7.97* (-2.38) | -11.65* (-2.14) | -12.36* (-2.26) | -13.42** (-2.69) | -8.63** (-2.79) |
Retinopathy (N = 0, Y = 1) | Â | Â | Â | Â | Â | 9.36 (1.86) |
Change in weight (BMI) | Â | Â | 7.40 (1.69) | Â | Â | Â |
Co-morbid conditions (number of diabetic related) | 1.43 (0.55) | Â | -0.22 (-0.01) | 1.83 (0.56) | 0.04 (0.01) | Â |
HbA1c Level (week 28) | -3.29** (-2.88) | -3.19* (-2.43) | Â | Â | -5.17*** (-3.87) | -3.19** (-2.65) |
Number of hypoglycemic events during day (active 7 am-11 pm) | -0.53** (-2.72) | -0.29 (-1.28) | -0.70** (-2.86) | -0.81** (-3.26) | -0.34 (-1.47) | -0.42* (-2.06) |
Number of hypoglycemic events during night (sleep 11 pm-7 am) | 0.29 (0.72) | 0.53 (1.14) | 0.71 (1.41) | -0.27 (-0.53) | 0.15 (0.32) | 0.36 (0.84) |
| Â | F = 65.351*** | F = 3.177* | F = 4.571*** | F = 5.657*** | F = 6.093*** | F = 4.027** |
| Â | R2 = 0.123 | R2 = 0.062 | R2 = 0.125 | R2 = 0.103 | R2 = 0.138 | R2 = 0.095 |
| Â | Adj R2 = 0.100 | Adj R2 = 0.043 | Adj R2 = 0.098 | Adj R2 = 0.085 | Adj R2 = 0.115 | Adj R2 = 0.072 |